ArticleCellular oncology (Dordrecht, Netherlands)2022

VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas.

Jiale Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.